Study of STYLAGE® XXL for Volume Deficiency in the Mid-Face

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 6, 2022

Primary Completion Date

May 15, 2024

Study Completion Date

April 25, 2025

Conditions
Volume Deficiency in the Mid-FaceAgingAesthetics
Interventions
DEVICE

STYLAGE® XXL

"Up to 2.0 mL will be injected in the zygomaticomalar region and optionally up to 2.0 mL in the anteromedial cheek at the first session, on each side of the face.~Up to 1.0 mL in the zygomaticomalar region and optionally up to 1.0 mL in the anteromedial cheek for the optional touch-up session, on each side of the face.~Up to 2.0 mL will be injected in the zygomaticomalar region and optionally up to 2.0 mL in the anteromedial cheek before study exit, on each side of the face."

DEVICE

STYLAGE® XXL

"Up to 2.0 mL will be injected in the zygomaticomalar region and optionally up to 2.0 mL in the anteromedial cheek at the first session, on each side of the face.~Up to 1.0 mL in the zygomaticomalar region and optionally up to 1.0 mL in the anteromedial cheek for the optional touch-up session, on each side of the face.~Up to 2.0 mL will be injected in the zygomaticomalar region and optionally up to 2.0 mL in the anteromedial cheek before study exit, on each side of the face."

Trial Locations (1)

Unknown

Centre Medical Saint Jean, Arras

Sponsors
All Listed Sponsors
collaborator

Avania B.V.

UNKNOWN

collaborator

Canfield Scientific Inc.

UNKNOWN

lead

Laboratoires Vivacy

INDUSTRY

NCT05355454 - Study of STYLAGE® XXL for Volume Deficiency in the Mid-Face | Biotech Hunter | Biotech Hunter